Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Abeona Therapeutics Inc ABEO

Healthcare Biotechnology
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The... see more

Recent & Breaking News (NDAQ:ABEO)

Abeona Announces Pricing of Public Offering of Common Stock and Pre?Funded Warrants

Thomson Reuters ONE December 20, 2019

Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA

GlobeNewswire December 20, 2019

Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants

GlobeNewswire December 19, 2019

Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants

Thomson Reuters ONE December 19, 2019

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

ACCESSWIRE IA December 19, 2019

Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm

Newsfile December 19, 2019

ABEO NOTICE: Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.- ABEO

GlobeNewswire December 18, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO

GlobeNewswire December 17, 2019

SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

ACCESSWIRE IA December 16, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Twitter, Inc. (TWTR)

ACCESSWIRE IA December 16, 2019

Abeona Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm

Newsfile December 16, 2019

ABEO LOSS ALERT: TOP RANKED ROSEN LAW FIRM Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action - ABEO

GlobeNewswire December 15, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO

ACCESSWIRE IA December 14, 2019

INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

ACCESSWIRE IA December 13, 2019

Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm

Newsfile December 13, 2019

Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Infosys Limited (INFY)

GlobeNewswire December 13, 2019

SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

ACCESSWIRE IA December 12, 2019

ABEO ALERT: Zhang Investor Law Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.- ABEO

GlobeNewswire December 12, 2019

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO

GlobeNewswire December 12, 2019

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E Corporation, Twitter, Sealed Air, and Abeona Therapeutics and Encourages Investors to Contact the Firm

GlobeNewswire December 11, 2019